Patritumab
Patritumab (U3-1287) is an anti-HER3 monoclonal antibody with potential antitumor activity and inhibits phosphorylation of EGFR, HER2, HER3, ERK, and AKT.Patritumab promotes apoptosis and inhibits proliferation in non-small cell lung cancer.
Product Specifications
CAS Number
1262787-83-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
ERK | EGFR | HER | Akt
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
S1014-55C1-ML650 100 µL
SMAD4, phosphorylated (Thr277) (Mothers Against Decapentaplegic Homolog 4, SMAD 4, Mothers Against DPP Homolog 4, Deletion Target In Pancreatic Carcinoma 4, MAD Homolog 4, SMAD Family Member 4, hSMAD4, DPC4, MADH4) (MaxLight 650) discontinued
Ask
View Details B9101-03-FITC 200 µL
BCHE, ID (Pseudocholinesterase, Butyrylcholine Esterase, Choline Esterase II, Acylcholine Acylhydrolase, Cholinesterase, CHE1) (FITC) discontinued
Ask
View Details 
GTR15331159 1 Vial
Lentiviral human GPR22 shRNA (UAS) - Lentiviral human GPR22 shRNA (UAS, iRFP) plasmid
Ask
View Details